Corium Innovations, Inc.

This study tested a new skin patch designed to deliver the drug ozanimod, which is used for multiple sclerosis and ulcerative colitis. Researchers compared how the body absorbs the drug from three different patch formulas versus the standard oral capsule. The goal was to see if t…

This small study aimed to see if a new generic version of a selegiline skin patch gets into the bloodstream the same way as the existing brand-name patch (EMSAM®). It involved 12 healthy adults who each wore both patches at different times. Researchers measured drug levels in the…